Recherche
-
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
(Nature Communications. vol. 12, n° 1, pp. 5215, 2021-09-01)Article de revueLibre accès -
New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project
(Journal of Clinical Medicine. vol. 10, n° 16, 2021-08-21)Article de revueLibre accès -
Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study
(Epidemics. vol. 46, pp. 100744, 2024-03-01)Article de revueLibre accès -
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
(eLife. vol. 11, pp. e75427, 2022-07-08)Article de revueLibre accès -
Evaluating the Use of Generalized Dynamic Weighted Ordinary Least Squares for Individualized Hiv Treatment Strategies
(Annals of Applied Statistics. vol. 17, n° 3, pp. 2432-2451, 2023-09)Article de revueLibre accès -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
(PLoS Medicine. vol. 19, n° 1, 2022-01-11)Article de revueLibre accès -
Global Variations in Event-Based Surveillance for Disease Outbreak Detection: Time Series Analysis
(JMIR Public Health and Surveillance. vol. 8, n° 10, 2022-10-31)Article de revueLibre accès -
Post-clustering difference testing: valid inference and practical considerations
(Computational Statistics and Data Analysis)Article de revueLibre accès -
Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health
(BMJ Evidence-Based Medicine, 2023-02-14)Article de revueLibre accès -
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
(EBioMedicine. vol. 80, 2022-06)Article de revueLibre accès